Stanford University

  Award Total: $18,605,450 # of Awards: 86 Home Page:

Investigators

  Adam Adler , BA- Karyn Angell , Ph.D.- Steven Artandi , M.D., Ph.D.- Steven Artandi , M.D., Ph.D.- Steven Artandi , M.D., Ph.D.- Speranza Avram , MPA- Jay Azarow , Ph.D.- Michael Bax , M.S.- Rachel Bitton , Ph.D.- Caroline Bliss-Isberg , Ph.D.- Caroline Bliss-Isberg , Ph.D.- Deborah Burkhart , Ph.D.- Robert Carlson , M.D.- Howard Chang , M.D, Ph.D.- Zhen Cheng , Ph.D.- Gilbert Chu , M.D.- Karlene Cimprich , Ph.D.- Karlene Cimprich , Ph.D.- Stanley Cohen , M.D.- Kate Collie , Ph.D.- Christopher Contag , Ph.D.- Matthew Cordova , Ph.D.- Bruce Daniel , M.D.- Bradley Ekstrand , M.D., Ph.D.- David Feldman , M.D.- Brian Feldman , M.D., Ph.D.- David Feldman , M.D.- James Ford , M.D.- Margaret Fuller , Ph.D.- Heinz Furthmayr , M.D.- Janine Giese-Davis , Ph.D.- Janine Giese-Davis , Ph.D.- Edward Graves , Ph.D.- Steven Hancock , M.D.- Brian Hargreaves , Ph.D.- Anne-Renee Hartman , M.D.- Melanie Hayden Gephart , MD- Peter Jackson , Ph.D.- Stefanie Jeffrey , M.D.- Stefanie Jeffrey , M.D.- Stefanie Jeffrey , M.D.- Stefanie Jeffrey , M.D.- Cheryl Koopman , Ph.D.- Cheryl Koopman , Ph.D.- Cheryl Koopman , Ph.D.- Cheryl Koopman , Ph.D.- Cheryl Koopman , Ph.D.- Cheryl Koopman , Ph.D.- Mary Anne Kreshka , M.A.- Mary Anne Kreshka , M.A.- Allison Kurian , M.D.- Allison Kurian , M.D.- Jennifer Lahti , M.S.- Frances Lau , M.S.- Craig Levin , Ph.D.- Ronald Levy , M.D.- Joseph Lipsick , M.D.,Ph.D.- Quan Lu , Ph.D.- Yuefeng Lu , Ph.D.- Patrick Lupardus , B.S.- Lisa McPherson , Ph.D.- Daria Mochly-Rosen , Ph.D.- Mark Pegram , M.D.- Sharon Pitteri , Ph.D.- Sylvia Plevritis , Ph.D.- Jonathan Pollack , M.D., Ph.D.- Jonathan Pollack , M.D., Ph.D.- Rebecca Rakow-Penner , M.S.- Kim Rhoads , M.D., M.P.H.- Stanley Rockson , M.D.- Glenn Rosen , M.D.- Yohei Shimono , M.D., Ph.D.- Tatana Spicakova , Ph.D.- David Spiegel , M.D.- David Spiegel , M.D.- David Spiegel , M.D.- Devon Thompson , M.Sc., Ph.D.- Brian Thorndyke , Ph.D.- Thea Tlsty , Ph.D.- Irene Wapnir , M.D.- Irene Wapnir , M.D.- Wensheng Wei , Ph.D.- Ronald Weigel , M.D., Ph.D.- Robert West , M.D., Ph.D.- Robert West , M.D., Ph.D.- Robert West , M.D., Ph.D.- Lynn Westphal , M.D.- Alice Whittemore , Ph.D., M.A.- Dieter Wolf , M.D.- Albert Wong , M.D.- Joseph Wu , M.D., Ph.D.- Dawn Yean , Ph.D.- Hong Zhang , Ph.D.-

Grants

Title[sort] Cycle Award[sort]
Targeting Internal Ribosome Entry Site Transacting Factors 2017 (Cycle 23) $236,225
 Investigator(s): Mark Pegram, M.D. 23IB-0010
Breast Cancer Care: Pilot Forum For Mental Health Providers 2016 (Cycle 22) $25,000
 Investigator(s): Irene Wapnir, M.D. 22MB-0001
Technologies for Augmented Reality Breast Surgery 2016 (Cycle 22) $232,647
 Investigator(s): Bruce Daniel, M.D. 22IB-0006
Cell-free tumor DNA in CSF decodes breast cancer brain mets 2015 (Cycle 21) $236,541
 Investigator(s): Melanie Hayden Gephart, MD 21IB-0105
Targeting Breast Cancer Metastasis to Bone 2014 (Cycle 20) $237,448
 Investigator(s): Christopher Contag, Ph.D. 20IB-0141
Drug to block double-strand break repair in breast cancer 2014 (Cycle 20) $160,500
 Investigator(s): Gilbert Chu, M.D. 20IB-0126
Sustainable Education to Eliminate Disparities (SEED) 2013 (Cycle 19) $24,975
 Investigator(s): Kim Rhoads, M.D., M.P.H. 19MB-0003
Vitamin D Signals Via a Novel Pathway to Inhibit Metastasis 2013 (Cycle 19) $236,068
 Investigator(s): Brian Feldman, M.D., Ph.D. 19IB-0103
Getting a jump on cancer with a genomic risk classifier 2013 (Cycle 19) $251,119
 Investigator(s): Robert West, M.D., Ph.D. 19IB-0124
Imaging, Genomics, and Glycoproteomics for Cancer Detection 2013 (Cycle 19) $235,348
 Investigator(s): Sharon Pitteri, Ph.D. 19IB-0140
Radiation-Induced Migration of Breast Cancer Cells 2013 (Cycle 19) $234,189
 Investigator(s): Edward Graves, Ph.D. 19IB-0106
Molecular classification of early breast neoplasia 2011 (Cycle 17) $156,561
 Investigator(s): Robert West, M.D., Ph.D. 17IB-0038
Vitamin D and Breast Cancer in Obesity: Therapeutic Trials 2011 (Cycle 17) $1,156,701
 Investigator(s): David Feldman, M.D. 17OB-0071
At-Home Group Video Calling to Support Rural Women 2011 (Cycle 17) $93,961
 Investigator(s): Cheryl Koopman, Ph.D. 17AB-1600
Measuring Real-World Breast Cancer Outcomes 2010 (Cycle 16) $1,066,225
 Investigator(s): Allison Kurian, M.D. 16OB-0149
Electronics for High Resolution Breast-Dedicated PET 2010 (Cycle 16) $75,924
 Investigator(s): Frances Lau, M.S. 16GB-0060
MRI Guided Focused Ultrasound in Breast Cancer Treatment 2010 (Cycle 16) $88,257
 Investigator(s): Rachel Bitton, Ph.D. 16FB-0090
Enhancing Trastuzumab Therapy with an NK Activating Antibody 2010 (Cycle 16) $224,749
 Investigator(s): Ronald Levy, M.D. 16IB-0095
Stroma Expression Patterns in Breast Cancer 2009 (Cycle 15) $188,097
 Investigator(s): Robert West, M.D., Ph.D. 15NB-0156A
Discovery of Fusion Genes in Breast Cancer 2009 (Cycle 15) $160,000
 Investigator(s): Jonathan Pollack, M.D., Ph.D. 15IB-0123
The Role of EGF Variant mLEEK and Grp78 in Breast Cancer 2009 (Cycle 15) $241,380
 Investigator(s): Albert Wong, M.D. 15IB-0080
Novel Tumor Suppressors in Breast Development and Cancer 2009 (Cycle 15) $230,373
 Investigator(s): Margaret Fuller, Ph.D. 15IB-0068
Imaging of Novel Stem Cell Therapy Targeting Breast Cancer 2008 (Cycle 14) $239,213
 Investigator(s): Joseph Wu, M.D., Ph.D. 14IB-0039
Novel Small Proteins for PET Imaging of Breast Cancer 2008 (Cycle 14) $261,806
 Investigator(s): Zhen Cheng, Ph.D. 14IB-0091
Functional Breast MRI with BOLD Contrast 2008 (Cycle 14) $75,994
 Investigator(s): Rebecca Rakow-Penner, M.S. 14GB-0004
Engineering EGFR Antagonists for Breast Tumor Targeting 2007 (Cycle 13) $75,992
 Investigator(s): Jennifer Lahti, M.S. 13GB-0161
Determinants of Response to Microtubule Stabilizing Drugs 2007 (Cycle 13) $66,302
 Investigator(s): Tatana Spicakova, Ph.D. 13FB-0144
Exploring the Role of PARP Inhibitors in Breast Cancer 2007 (Cycle 13) $157,516
 Investigator(s): Karlene Cimprich, Ph.D. 13IB-0029
Expanding Rural Access: Distance Delivery of Support Groups 2007 (Cycle 13) $290,337
 Investigator(s): Cheryl Koopman, Ph.D. 13BB-2400
Multinuclear MRI of Breast Tumors 2007 (Cycle 13) $236,771
 Investigator(s): Brian Hargreaves, Ph.D. 13IB-0074
Telomerase, Mammary Stem Cells, and Breast Cancer 2007 (Cycle 13) $360,277
 Investigator(s): Steven Artandi, M.D., Ph.D. 13NB-0179
Novel Regulation of the Rb Pathway in Breast Epithelium 2007 (Cycle 13) $74,808
 Investigator(s): Deborah Burkhart, Ph.D. 13GB-0150
MYC and CSN5 in the Breast Cancer "Wound Signature" Profile 2006 (Cycle 12) $76,000
 Investigator(s): Adam Adler, BA 12GB-0008
Breast Cancer Metastasis: a Heritable Trait? 2006 (Cycle 12) $264,595
 Investigator(s): Alice Whittemore, Ph.D., M.A. 12IB-0167
Breast Tumor Inhibition by Vitamin D in a Mouse Model 2006 (Cycle 12) $234,388
 Investigator(s): David Feldman, M.D. 12IB-0074
A Targeted Therapy for Wound-like Breast Cancers 2006 (Cycle 12) $232,934
 Investigator(s): Howard Chang, M.D, Ph.D. 12IB-0063
New Technology to Enhance PET Imaging of Breast Cancer 2006 (Cycle 12) $154,879
 Investigator(s): Craig Levin, Ph.D. 12IB-0092
Real-Time 3D Ultrasound Image-Guidance for Breast Surgery 2006 (Cycle 12) $66,141
 Investigator(s): Michael Bax, M.S. 12GB-0148
Analysis of MicroRNA Expression in Breast Cancer Stem Cells 2006 (Cycle 12) $134,976
 Investigator(s): Yohei Shimono, M.D., Ph.D. 12FB-0053
Stem Cells of Molecularly Diverse ER-Negative Breast Cancers 2005 (Cycle 11) $234,165
 Investigator(s): Stefanie Jeffrey, M.D. 11IB-0175
The Role of B-Myb in Human Breast Cancer Progression 2005 (Cycle 11) $156,106
 Investigator(s): Joseph Lipsick, M.D.,Ph.D. 11IB-0138
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2 2005 (Cycle 11) $234,071
 Investigator(s): Stanley Rockson, M.D. 11IB-0172
Role of Telomerase in Mammary Stem Cell Function 2005 (Cycle 11) $236,379
 Investigator(s): Steven Artandi, M.D., Ph.D. 11IB-0174
Cost-effectiveness of Breast MRI Screening by Cancer Risk 2005 (Cycle 11) $49,647
 Investigator(s): Allison Kurian, M.D. 11FB-0051
Removing Respiratory Artifacts in Nuclide Breast Imaging 2005 (Cycle 11) $31,556
 Investigator(s): Brian Thorndyke, Ph.D. 11FB-0170
Characterizing Breast Cancer Cells in Blood and Bone Marrow 2004 (Cycle 10) $155,781
 Investigator(s): Robert Carlson, M.D. 10IB-0073
Expanding Rural Access: Distance Delivery of Support Groups 2004 (Cycle 10) $62,656
 Investigator(s): Cheryl Koopman, Ph.D. 10AB-2801
Profiling Enzyme Activities in Human Breast Cancer 2004 (Cycle 10) $400,000
 Investigator(s): Stefanie Jeffrey, M.D. 10EB-1086
'Art for Recovery': Expanding Access for the Underserved 2003 (Cycle IX) $83,368
 Investigator(s): Kate Collie, Ph.D. 9FB-0115
Assessing the Impact of Shame and Guilt in Recovery 2003 (Cycle IX) $152,094
 Investigator(s): Janine Giese-Davis, Ph.D. 9IB-0191
Interactive Technology to Support Rural Women and Families 2003 (Cycle IX) $3,333
 Investigator(s): Cheryl Koopman, Ph.D. 9AB-1400
Interactive Technology to Support Rural Women and Families 2003 (Cycle IX) $3,333
 Investigator(s): Mary Anne Kreshka, M.A. 9AB-1400
Chemotherapy-Induced Ovarian Damage: Prevention and Impact 2002 (Cycle VIII) $82,027
 Investigator(s): Lynn Westphal, M.D. 8AB-1700
Breast Stromal Genes Act as Early Markers of Malignancy 2002 (Cycle VIII) $398,072
 Investigator(s): Stefanie Jeffrey, M.D. 8EB-1106
Breast Stromal Genes Act as Early Markers of Malignancy 2002 (Cycle VIII) $398,072
 Investigator(s): Thea Tlsty, Ph.D. 8EB-1106
Using Microarrays to Estimate Breast Cancer Risk 2002 (Cycle VIII) $34,233
 Investigator(s): Bradley Ekstrand, M.D., Ph.D. 8FB-0108
Understanding Telomere Dynamics in the Breast 2002 (Cycle VIII) $681,564
 Investigator(s): Steven Artandi, M.D., Ph.D. 8PB-0155
Regulation of the Rad1 Checkpoint Complex in Breast Cancer 2002 (Cycle VIII) $59,987
 Investigator(s): Patrick Lupardus, B.S. 8GB-0091
Genetic Alterations in MRI Screen-Detected Breast Lesions 2002 (Cycle VIII) $145,649
 Investigator(s): James Ford, M.D. 8DB-0153
Genetic Alterations in MRI Screen-Detected Breast Lesions 2002 (Cycle VIII) $145,649
 Investigator(s): Sylvia Plevritis, Ph.D. 8DB-0153
Identifying Sources of Genomic Instability in Breast Cancer 2002 (Cycle VIII) $119,059
 Investigator(s): Karlene Cimprich, Ph.D. 8IB-0090
Locating Novel Breast Cancer Genes using DNA Microarrays 2002 (Cycle VIII) $477,295
 Investigator(s): Jonathan Pollack, M.D., Ph.D. 8KB-0135
The Role of BRCA1 in Nucleotide Excision Repair 2001 (Cycle VII) $85,968
 Investigator(s): Anne-Renee Hartman, M.D. 7FB-0077
Selective Targeting of Breast Cancer with Radioiodide 2001 (Cycle VII) $315,200
 Investigator(s): Irene Wapnir, M.D. 7WB-0137
Regulation of the ATR Checkpoint Response in Breast Cancer 2001 (Cycle VII) $86,297
 Investigator(s): Dawn Yean, Ph.D. 7FB-0157
Genes That Modulate Dioxin-Induced Breast Cancer 2001 (Cycle VII) $84,731
 Investigator(s): Quan Lu, Ph.D. 7FB-0123
Does a Peer Navigator Improve Quality of Life at Diagnosis? 2001 (Cycle VII) $772,073
 Investigator(s): David Spiegel, M.D. 7BB-2400S
Does a Peer Navigator Improve Quality of Life at Diagnosis? 2001 (Cycle VII) $772,073
 Investigator(s): Caroline Bliss-Isberg, Ph.D. 7BB-2400S
Genes Determining Estrogen Susceptibility in Breast Cancer 2000 (Cycle VI) $86,400
 Investigator(s): Wensheng Wei, Ph.D. 6FB-0106
Does a Peer Navigator Improve Quality of Life at Diagnosis? 2000 (Cycle VI) $159,147
 Investigator(s): David Spiegel, M.D. 6AB-1100
Does a Peer Navigator Improve Quality of Life at Diagnosis? 2000 (Cycle VI) $159,147
 Investigator(s): Caroline Bliss-Isberg, Ph.D. 6AB-1100
Metastasis Suppressor Genes for Breast Cancer 2000 (Cycle VI) $312,937
 Investigator(s): Stanley Cohen, M.D. 6JB-0008
The Control of Breast Cancer Cell Death 2000 (Cycle VI) $306,149
 Investigator(s): Daria Mochly-Rosen, Ph.D. 6JB-0056
GATA-3 Expression in Hormone Responsive Breast Cancer 1999 (Cycle V) $232,444
 Investigator(s): Ronald Weigel, M.D., Ph.D. 5JB-0047
Cloning of Senescence Genes in Mammary Epithelial Cells 1999 (Cycle V) $75,034
 Investigator(s): Hong Zhang, Ph.D. 5FB-0067
Generativity and Meaning-making as Resilience Factors in Br 1999 (Cycle V) $0
 Investigator(s): Jay Azarow, Ph.D. 5FB-0168
Do Community Cancer Groups Enhance Well-being? 1999 (Cycle V) $74,968
 Investigator(s): Matthew Cordova, Ph.D. 5FB-0036
Role of the POP1 Gene in Breast Cancer Genomic Stability 1999 (Cycle V) $112,710
 Investigator(s): Peter Jackson, Ph.D. 5JB-0121
Characterization of hAG-2 and Its Role in Breast Cancer 1999 (Cycle V) $166,465
 Investigator(s): Devon Thompson, M.Sc., Ph.D. 5KB-0083
Breast Cancer Gene Expression Using Amplified Core Biopsies 1999 (Cycle V) $155,286
 Investigator(s): Stefanie Jeffrey, M.D. 5JB-0126
A Support Group Alternative for Rural and Isolated Women 1999 (Cycle V) $588,328
 Investigator(s): Cheryl Koopman, Ph.D. 5BB-1801
A Support Group Alternative for Rural and Isolated Women 1999 (Cycle V) $588,328
 Investigator(s): Mary Anne Kreshka, M.A. 5BB-1801
Breast Cancer Screening in Women Surviving Hodgkin's Disease 1999 (Cycle V) $1,033,898
 Investigator(s): Steven Hancock, M.D. 5PB-0165
Do Community Cancer Support Groups Reduce Physiologic Stress 1998 (Cycle IV) $726,152
 Investigator(s): David Spiegel, M.D. 4BB-2901
A Novel Drug Induces Apoptosis in Breast Cancer Cells 1998 (Cycle IV) $228,595
 Investigator(s): Glenn Rosen, M.D. 4JB-0057
A Community-based Workbook for Helping Rural Cancer Patients 1997 (Cycle III) $58,512
 Investigator(s): Cheryl Koopman, Ph.D. 3AB-1301
Control of DNA Replication in Breast Cancer 1997 (Cycle III) $47,543
 Investigator(s): Dieter Wolf, M.D. 3FB-0021
Modulation of Drug Resistance by Protein Kinase C Inhibitors 1997 (Cycle III) $24,182
 Investigator(s): Yuefeng Lu, Ph.D. 3FB-0056
Estrogen Receptor Regulation in Breast Cancer 1995 (Cycle I) $75,238
 Investigator(s): Lisa McPherson, Ph.D. 1FB-0377
Does Change in Emotional Expression Mediate Cancer Survival? 1995 (Cycle I) $74,848
 Investigator(s): Janine Giese-Davis, Ph.D. 1FB-0383
Effects of Stress and Support on Delay in Cancer Treatment 1995 (Cycle I) $76,087
 Investigator(s): Karyn Angell, Ph.D. 1FB-0490
Malignant Transformation in Breast Epithelium 1995 (Cycle I) $54,000
 Investigator(s): Heinz Furthmayr, M.D. 1SB-0004